Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

Clinicians Take Heed—High BP Merits Quick Action, Data Suggest

Caitlin E. Cox

July 17, 2025

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Todd Neale

August 23, 2024

News Daily News

Payment Parity for Telehealth Linked to Better BP Treatment

Michael O'Riordan

August 07, 2024

News Daily News

Remote Monitoring May Curb Recurring BP Problems of Pregnancy

L.A. McKeown

June 13, 2024

News Daily News

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

L.A. McKeown

April 12, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

L.A. McKeown

June 04, 2021

News Daily News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Todd Neale

January 13, 2021

News Daily News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Michael O'Riordan

January 12, 2021

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Daily News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Shelley Wood

May 29, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

December 2025 Dispatch for the CV Team

November 2025 Dispatch for the CV Team

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Clinicians Take Heed—High BP Merits Quick Action, Data Suggest

Reimbursement Issues Seem to Be Holding Renal Denervation Back

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Payment Parity for Telehealth Linked to Better BP Treatment

Remote Monitoring May Curb Recurring BP Problems of Pregnancy

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

February 2023 News Roundup

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

More Women Than Men Develop HF or Die After STEMI

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content